A Size‐Changeable Collagenase‐Modified Nanoscavenger for Increasing Penetration and Retention of Nanomedicine in Deep Tumor Tissue
- 27 February 2020
- journal article
- research article
- Published by Wiley in Advanced Materials
- Vol. 32 (16) , e1906745
Abstract
The complex tumor microenvironment constitutes a variety of barriers to prevent nanoparticles (NPs) delivery and results in extremely low accumulation of nanomedicines in solid tumors. Here, a newly developed size‐changeable collagenase‐modified polymer micelle is employed to enhance the penetration and retention of nanomedicine in deep tumor tissue. The TCPPB micelle is first formed by self‐assembly of maleimide‐terminated poly(ethylene glycol)‐block‐poly(β‐amino ester) (MAL‐PEG‐PBAE) and succinic anhydride‐modified cisplatin‐conjugated poly(ε‐caprolactone)‐block‐poly(ethylene oxide)‐triphenylphosphonium (CDDP‐PCL‐PEO‐TPP). Next, Col‐TCPPB NPs are prepared through a “click” chemical combination of thiolated collagenase and maleimide groups on TCPPB micelle. Finally, biocompatible chondroitin sulfate (CS) is coated to obtain CS/Col‐TCPPB NPs for avoiding collagenase inactivation in blood circulation. In tumor acidic microenvironment, the hydrophobic PBAE segments of the resultant micelles become hydrophilic, leading to a dissociation and subsequent dissolution of partial collagenase‐containing components (Col‐PEG‐PBAE) from NPs. The dissolved Col‐PEG‐PBAE promotes the digestion of collagen fibers in tumor tissue like a scavenger, which enhances the NPs penetration. Simultaneously, the increased hydrophilicity of residual Col‐PEG‐PBAE in the micellar matrix causes an expansion of the NPs, resulting in an enhanced intratumoral retention. In tumor cells, the NPs target to release the cisplatin drugs into mitochondria, achieving an excellent anticancer efficacy.Keywords
Funding Information
- China National Funds for Distinguished Young Scientists (51725303)
- National Natural Science Foundation of China (21574105)
- Sichuan Province Youth Science and Technology Innovation Team (2016TD0026)
This publication has 42 references indexed in Scilit:
- Nanoparticles Functionalized with Collagenase Exhibit Improved Tumor Accumulation in a Murine Xenograft ModelParticle & Particle Systems Characterization, 2014
- Self-Regulated Multifunctional Collaboration of Targeted Nanocarriers for Enhanced Tumor TherapyBiomacromolecules, 2014
- Bromelain Surface Modification Increases the Diffusion of Silica Nanoparticles in the Tumor Extracellular MatrixACS Nano, 2014
- Delivery of platinum(IV) drug to subcutaneous tumor and lung metastasis using bradykinin-potentiating peptide-decorated chitosan nanoparticlesBiomaterials, 2014
- Detouring of cisplatin to access mitochondrial genome for overcoming resistanceProceedings of the National Academy of Sciences, 2014
- Multifaceted Transport Characteristics of Nanomedicine: Needs for Characterization in Dynamic EnvironmentMolecular Pharmaceutics, 2013
- Multifunctional Albumin Nanoparticles As Combination Drug Carriers for Intra‐Tumoral ChemotherapyAdvanced Healthcare Materials, 2013
- Nanomedicine : A Great First Year And, with Your Help, A Bright Future AheadNanomedicine, 2007
- Intraperitoneal Immunotherapy for Metastatic Ovarian Carcinoma: Resistance of Intratumoral Collagen to Antibody PenetrationClinical Cancer Research, 2006
- Proteolytic Surface Functionalization Enhancesin VitroMagnetic Nanoparticle Mobility through Extracellular MatrixNano Letters, 2006